NC Pharma Locks Down $680M Deal With. U.S. As Smallpox Drug Suddenly in High Demand
A feature story about biopharmaceutical company Chimerix, led by CEO Michael Sherman T’92, which secured a contract to supply the U.S. with a drug that could be used to fight the monkeypox outbreak.